Dabur India is one of the leading fast moving consumer goods companies (FMCG) in India. The 132-year old Ayurvedic/Herbal company deals in more than 260 consumer products.
Dabur India’s Market Capitalisation
The market capitalisation of the company, as of March 2018, is close to Rs.57,407 crore.
Dabur’s Wealth and Recent PerformanceQ1 FY 2018-19
The key highlights of the company’s financial performance for the Q1, FY 2018-19, ended 30 June 2018 are as follows:
- The consolidated net profit recorded an increase of 24.6% and stood at Rs.329.22 crore.
- The company’s consolidated revenue registered a growth of 19.6% and stood at Rs.2,080.70 crore. The growth was attributed to a strong double-digit growth across all of Dabur’s key categories like home care and foods, health supplements, hair care, oral care, and skin care.
- The standalone India Revenue reported an increase by 24.7% and stood at Rs.1,473.1 crore.
- The domestic FMCG business reported a volume growth of 21%.
- Meanwhile, the company’s international business reported a 10.5% growth.
- The company’s Home Care and Oral Care businesses reported an over 17% growth
- The company’s shampoo business recorded an increase of more than 30% while the Dabur Honey sales jumped by around 42%.
- Dabur’s skin care category grew by 27.1% while the Foods business recorded a growth by over 26% in the first quarter. The company’s digestive biscuits business jumped by nearly 22%.
The key highlights of the company’s financial performance for the Q4 FY 2017-18, ended 31 March 2018 are as follows:
- The company’s consolidated revenue for Q4 recorded a growth of 11.1% and stood at Rs.2,032.91 crore.
- During the Q4, the consolidated net profit reported an increase of 18.9% and stood at Rs.396.20 crore.
- The standalone net profit registered growth at 17% and stood at Rs.353.58 crore.
- The company’s standalone India revenue stood at Rs.1,509.62 crore and recorded an increase of 10%.
- The domestic FMCG business reported an underlying Volume Growth of 7.7%.
- India operating margin recorded an exceptional increase of 27.2%.
- In the Q4, the company’s shampoo business recorded an increase of more than 31% while the Dabur Honey sales jumped by around 24%.
- The company’s health supplements category registered a growth of 14% while the toothpaste sales reported a 14% growth.
- The health care category reported a growth of more than 11%. Meanwhile, the hair oils business jumped 9%.
The key highlights of the company’s financial performance for the full FY 2017-18, ended 31 March 2018 are as follows:
- For the entire year, Dabur India recorded an increase of 6.9% in the consolidated revenue.
- The consolidated net profit jumped by 6.1% and stood at Rs.1,354.39 crore.
- The comparable standalone revenue registered an increase of 8.3%.
- The company’s standalone net profit was up by 7.4% growth and stood at Rs.1,072.05 crore.
- The company recorded a revenue growth of 17.7% for the year ended December 31, 2017. The volume growth for the same period was 13%.
- Dabur’s consolidated revenue was Rs 1,966.4 crore, up 6.1% from Rs 1,852.9 crore a year earlier. Meanwhile, the company’s consolidated net profit for the third quarter was up 13.1% growth at Rs 332 Crore, up from Rs 294 crore a year earlier.
- The net profit of Dabur India showed a growth of a 15.9% during the third quarter at Rs 265.5 crore, up from Rs.229 crore a year earlier.
- In September 2017, Dabur India teamed up with Amazon India to expand its online retail presence.
- Dabur had agreed to buy two South African cosmetic companies - D&A Cosmetics Proprietary Ltd. and Atlanta Body & Health Products Proprietary Ltd. in 2017.
Dabur Stock Trends in 2018
- The stock price of the company at the beginning of January was Rs. 351 on NSE and BSE. By the end of the month, the price did not see a massive change and reached to Rs. 359 at NSE and BSE.
- At the beginning of February the stock price did not change much and was at Rs. 357 and it continued to fall to Rs. 328 by the end of the month.
- The price of the stock at the beginning of March was Rs.326 on NSE. It was stable for most of the month and declined marginally towards the end. The scrip stood at Rs.323 by the end of March.
- In the month of April, the stock price continued to gradually increase throughout the month. It increased by around 40 points and ended the month at Rs.368.
- The scrip increased marginally by around 12 points in the month of May. By the end of May, the price of the stock stood at Rs.383.
- The stock price in August picked up the pace and reached Rs.486 by the end of the month. The opening price of the stock by the end of the month stood at Rs.483.
- The price of the stock in September fell by around 25 points. As on 17 September 2018, the price of the stock stood at Rs.468.
Dabur Stock Trends in 2016 and 2017
- The stock price of Dabur at the start of 2016 was Rs. 276 on NSE and BSE. It continued to fall throughout the month and was at Rs.242 by the end of February on both NSE and BSE.
- In the month of March, the stock price was flat and did not change much till the end of April as it was Rs. 272. The increase in the price was due to a 16% increase in net profit for Q4 FY16.
- Dabur’s stock price rose steadily throughout the month of May and crossed the Rs.300 mark by the end of June. In August the stock price started to fall and was Rs.268 by the end of September.
- At the beginning of November, the stock price was Rs.292 and fell to Rs.272 by the end of December 2016.
- The stock price at the beginning of January 2017 was Rs.278 and did not change much till the end of February. At the end of April, the stock price crossed Rs.290.
- The price did not change much throughout May and closed again at Rs.290 by the end of June. Dabur’s stock price crossed the Rs.300 mark in July and reached just about Rs.310 till the end of September.
- In beginning of November, the share price was Rs.325 and reached Rs.345 at the end of December 2017.
Should you invest in Dabur?
The share price of the company has not increased much since 2016. It has not seen an exponential growth in the past two years and the price has been growing at a slow rate. However, the company has been focusing on expansion and has a good chance or expecting profits. It is advisable to do enough research before investing in the stock.
Dabur operates via 3 business units - consumer care division (CCD), international business division (IBD) and consumer health division (CHD). The company's portfolio includes Hajmola (digestives), Real (fruit juices and beverages), Vatika (personal care) and Fem (fairness bleaches and skin care products). The company is present in all the important product categories like home care and foods, hair and skin care. The Ayurvedic company’s products are present in a total of more than 120 countries worldwide that covers over 6 million retail outlets. Russia, U.S., Middle East, SAARC and Europe are some of the big countries where Dabur brands are quite popular. It has a total of 19 state-of-t manufacturing facilities worldwide.
History of the Company
Dabur was established in 1884 in Kolkata by Dr. S.K. Burman following which a manufacturing plant was set up in 1896. The company entered into the Ayurvedic medicines in early 1900. Dabur became a Public Limited Company as Dabur India Ltd. in 1986. In 1996, the company created 3 separate divisions - Health Care, Products Division, Family Product Division & Dabur Ayurvedic Specialities Limited. In a bid to bring corporate governance, Dabur appointed a non-family professional CEO for the first time in 1998.
The company’s turnover crossed Rs.1,000 crore mark in 2000 and $2 billion mark market capitalisation in 2006. Dabur made its first overseas acquisition in July 2010 by buying personal care company Hobi Kozmetik Group in Turkey, for $69 million. The same year, it also bought Namaste Laboratories in the US for $100 million. In 2012, the company crossed the billion-dollar turnover mark during the 2011-12 while the $5 billion market cap mark was surpassed in 2013.
Sunil Duggal - CEO, Dabur India and International
Sunil has been working as the Chief Executive Officer at Dabur India and International since April 2002. He was appointed as the General Manager - Personal Care Business, at Dabur in 1995. He soon became the Vice President of Sales and Marketing in 1998 following which he was appointed as the Executive Director of the Board in 2000. He is an alumnus of IIM Kolkata and holds a degree of Engineering from BITS, Pilani.
Mohit Malhotra - CE0, Dabur India Ltd.
Mohit Malhotra will join Dabur India Ltd. as the Chief Executive Officer w.ef. From April 2018. He was previously working as the Head of Marketing at Dabur India Ltd. Mohit has an experience of more than 23 years, Ltd. in Dabur group in various capacities. In addition to his role at Dabur, Mohit serves as a Director of Dermoviva Skin Essentials Inc. and Weikfield International (UAE) LLC. He has done Master of Business Administration from Pune University.
Dabur Listings in NSE, BSE and Indices
The stocks of Dabur can be bought and sold on the two major stock exchanges in the country - National Stock Exchange and Bombay Stock Exchange. The codes for the same are mentioned below.
BSE - 500096
NSE - DABUR
ISIN - INE016A01026
Sector -Personal Care
Dabur Finance Listing and Indices:
Dabur forms a part of different indices and they are mentioned below:
- Nifty 100
- Nifty 500
- Nifty 200
- Nifty Next 50
- Nifty FMCG
- S&P BSE 100
- S&P BSE 500
- S&P BSE 200
8/3, Asaf Ali Road,
New Delhi – 110 002
Tel: +91 (011) 23253488
Dabur India Limited
Ghaziabad - 201010
Uttar Pradesh, India
Tel: +91 (0120) 3962100, 39412525, 4182100
Stocks vs. Mutual Funds: here's what we recommend
Stock market investments require a lot of research and knowledge. They do not generally offer any tax benefits and are regarded as high-risk investments. Hence,it is crucial to have a diversified portfolio. At Bankbazaar, we encourage our readers to invest on mutual funds . It doesn't require a lot of knowledge and equity linked mutual fund schemes offer tax benefits. Additionally, since mutual funds comprise stocks from multiple companies, they help in building a diversified portfolio.
The contents of this post/blog does not constitute financial or other professional advice nor does it imply in any manner a principal-agent relationship, and is not a professional advice on a specific financial matter.